The RESTORE HF study was conducted in a real-world setting to ascertain the effectiveness & tolerability of a fixed dose combination of torsemide & spironolactone in HF patients in India.
A 49-year-old male with uncontrolled hypertension presented with hypertensive emergency and HFrEF due to primary aldosteronism. Click here to learn more about the management approach that was followed.